Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.
How to adapt to choppy waters in biotech ecosystem – Pharmaceutical Technology
At the Outsourcing in Clinical Trials Conference in New England, experts shared insights on how the US clinical trial and pharmaceutical space could keep up
November 11, 2024